STAT+: Cadence raises $100 million to automate chronic disease care with regulated AI

Cadence, a digital health startup, has secured $100 million in funding to bolster its efforts to manage chronic diseases through AI-driven automation. This significant investment, valuing the company at $1.23 billion, underscores the growing confidence in AI's potential to revolutionize healthcare. By leveraging regulated AI, Cadence aims to provide more efficient and personalized care for chronic conditions, potentially improving patient outcomes and reducing healthcare costs on a broader scale. This move highlights a pivotal shift in how we approach long-term health management.